Boston Scientific (BSX) Cash from Operations (2009 - 2026)

Boston Scientific's Cash from Operations history runs 18 years deep, the most recent figure standing at 348000000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 35.67% year-over-year to 348000000.0; the TTM figure through Mar 2026 stood at 4341000000.0 (up 13.88% YoY), while the FY2025 annual figure was 4534000000.0, up 31.99% from the prior year.
• Cash from Operations came in at 348000000.0 for Q1 2026 at Boston Scientific, down from 1364000000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 1456000000.0 in Q4 2024 to a low of 58000000.0 in Q1 2022.
• A 5-year average of 726235294.12 and a median of 698000000.0 in 2023 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations sank 120.42% in 2022 and surged 427.59% in 2023, its largest moves.
• Boston Scientific's Cash from Operations stood at 807000000.0 in 2022, then climbed by 18.59% to 957000000.0 in 2023, then surged by 52.14% to 1456000000.0 in 2024, then retreated by 6.32% to 1364000000.0 in 2025, then sank by 74.49% to 348000000.0 in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered 348000000.0, 1364000000.0, and 1343000000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison